In this regard, a recent study has demonstrated the inhibition of human rhabdomyosarcoma xenografts by rapamycin through its effect on HH effector genes such as Gli1 and Gli 2 as well as PTCH1 and PATCH2 [63]. This evidence concerns the gene PTCH1 and rhabdomyosarcoma.